A 204

Known as: A-204, antibiotic A 204 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1981-2016
01219812016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Multidrug resistance is a common problem in the treatment of childhood rhabdomyosarcoma (RMS). Therefore, novel treatment regimes… (More)
Is this relevant?
2006
2006
Effectiveness of conventional cytotoxic treatment of rhabdomyosarcoma (RMS) may be limited by the development of multidrug… (More)
Is this relevant?
2004
2004
Sarcomas are one of the most refractory diseases among malignant tumors. More effective therapies based on an increased… (More)
Is this relevant?
2004
2004
Soft-tissue sarcomas are mesenchymal tumors that respond poorly to systemic chemotherapy. Suicide gene therapy may be an… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
2003
2003
Paediatric solid tumours exhibit steep dose-response curves to alkylating agents and are therefore considered candidates for high… (More)
Is this relevant?
1995
1995
We have examined the expression of 72-kDa gelatinase/type IV collagenase or matrix metalloproteinase-2 (MMP-2) and ist inhibitor… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
Is this relevant?
1993
1993
Many cancer cells show aberrant adhesion properties that likely contribute to tumorigenesis, invasion, and metastasis. Here, we… (More)
Is this relevant?
1993
1993
Most rhabdomyosarcomas are poorly differentiated malignant tumors. Dimethyl sulfoxide has been shown to modulate cell… (More)
Is this relevant?
1989
1989
Natural killer (NK) cells and NK cell activity were determined in three groups (newly diagnosed [n = 21], on therapy [n = 21… (More)
Is this relevant?
1983
1983
Mouse monoclonal antibodies against the human mammary carcinoma cell line, MCF-7, were produced and tested against a panel of… (More)
Is this relevant?